Billie, Kimao T.
HRN: 10-07-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/05/2023
02/18/2023
IV
2.25
Q6
CAP HR (Renal Dose)
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes